54Indexed trials
mesh condition
Depressive Disorder
Intelligence
Depressive Disorder intelligence: 54 indexed trials, 13 recruiting studies, 50 sponsors across 13 countries.
13Recruiting
50Sponsors
13Countries
Leading sponsors
University of North Carolina, Chapel Hill20 recruiting
University Hospital, Strasbourg, France20 recruiting
University of Oxford21 recruiting
GlaxoSmithKline20 recruiting
Dana-Farber Cancer Institute10 recruiting
Eli Lilly and Company10 recruiting
Beijing HuiLongGuan Hospital11 recruiting
Chen Li10 recruiting
George Washington University10 recruiting
H. Lundbeck A/S10 recruiting
Indiana University10 recruiting
First Affiliated Hospital of Chongqing Medical University10 recruiting
Geographic activity
United States23trials
United Kingdom6trials
China6trials
Australia3trials
Canada3trials
Turkey (Türkiye)2trials
Israel1trials
Nepal1trials
Russia1trials
Spain1trials
France1trials
Germany1trials
Leading interventions
Ketamine2trials
Bazedoxifene/Conjugated Estrogen1trials
Brainsway H7-Coil Deep TMS System1trials
Behavioral task performance1trials
Blended intervention (UP-APP)1trials
Brainsway H4-Coil Deep TMS System1trials
Behavioral and Affective Skills in Coping (BASIC)1trials
Centanafadine1trials
Chinese translated LETS ACT1trials
Citalopram1trials
Classical rTMS (transcranial magnetic stimulation)1trials
Attention Modification1trials
Methodology note
This entity is derived from structured ClinicalTrials.gov conditions and/or MeSH normalization. Counts reflect the current NeuroRisk indexed corpus and are not guaranteed exhaustive global totals.